Nadia Luheshi

1.7k citations
35 papers · 1.1k indexed · h-index 13
Topics
Cancer Immunotherapy and Biomarkers (14 papers)Immune cells in cancer (10 papers)Immunotherapy and Immune Responses (9 papers)

In The Last Decade

Nadia Luheshi

31 papers receiving 1.0k citations

Peers

Nadia Luheshi
Comparison fields: 5 of 88
  • Immunology 547
  • Molecular Biology 536
  • Oncology 270
  • Neurology 88
  • Epidemiology 76
Replace Myoungsun Son with:
Myoungsun Son United States
Pervinder Sagoo United Kingdom
Bradley N. Martin United States
Pam Hall Australia
Vicky L. Morrison United Kingdom
Alexander Hooftman Ireland
Joshua S. Stoolman United States
Masanao Saio Japan
Carole Berruyer-Pouyet France
Chaoming Mao China
Nadia Luheshi relative to Myoungsun Son United States Myoungsun Son's profile →
Citations per field
00.5×1.5×2.4×
Myoungsun Son · 1×
Citations per year

Countries citing papers authored by Nadia Luheshi

Since Specialization
Citations

This map shows the geographic impact of Nadia Luheshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Luheshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Luheshi more than expected).

Fields of papers citing papers by Nadia Luheshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Luheshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Luheshi. The network helps show where Nadia Luheshi may publish in the future.

Co-authorship network of co-authors of Nadia Luheshi

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Luheshi. A scholar is included among the top collaborators of Nadia Luheshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Luheshi. Nadia Luheshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 9
4 7
5 2
6 12
7 1
8 3
9 1
10 1
11 66
12 137
13 78
14 58
15 11
16 76
17 77
18 114
19 39
20 33

About Nadia Luheshi

Nadia Luheshi is a scholar working on Immunology, Oncology and Physiology, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Immune cells in cancer (10 papers) and Immunotherapy and Immune Responses (9 papers). The work is most often cited by research in Immunology (547 citations), Biological Psychiatry (30 citations) and Neurology (88 citations). Nadia Luheshi has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include David Brough, Gloria López‐Castejón, Krisztina Kovács, Ádám Dénes, James Giles, James Legg, Sabine L. Flitsch, Nancy J. Rothwell, Stephen High and Eileithyia Swanton. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026